Vorinostat
A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
Year introduced: 2019 (1998)
PubMed search builder options
Subheadings:
Tree Number(s): D02.065.199.960, D02.092.146.113.960, D02.092.570.394.690, D02.241.511.372.690
MeSH Unique ID: D000077337
Registry Number: 58IFB293JI
Entry Terms:
- N-Hydroxy-N'-phenyloctanediamide
- N Hydroxy N' phenyloctanediamide
- N1-Hydroxy-N8-phenyloctanediamide
- N1 Hydroxy N8 phenyloctanediamide
- Suberanilohydroxamic Acid
- Suberoyl Anilide Hydroxamic Acid
- Suberoylanilide Hydroxamic Acid
- NHNPODA
- Zolinza
- M344
- 18F-SAHA
- 18F-Suberoylanilide Hydroxamic Acid
- 18F Suberoylanilide Hydroxamic Acid
- MK-0683
- MK 0683
- MK0683
Pharmacologic Action: